Multiple News Streams
Bioalert monitors company press releases, FDA approvals, SEC filings and social media streams
Receive notifications via SMS, Telegram, Email, Whatsup, Signal, Voice mail, Alexa and much more
Bioalert also provides useful insights and sentiments (and it really works!) for your favourite biotech stocks
Investing in biotech companies requires up-to-date and timely information. Bioalert constantly monitors press releases, FDA approvals, SEC filings, and social media streams. Whether it is a Phase III trial result, FDA approval for a drug, or any clinical trial results, Bioalert notifies you immediately.
All plans include 30-day trials. Cancel anytime.
Save 25% with a yearly plan.
- 100+ Biotech companies
- Real-time SMS Notifications
- 7/24 Support
- Free upgrade to Plus plan *
- Everything in Basic, plus:
- 250+ Biotech companies
- Select Stocks
- All-in-one Dashboard
- Twitter and Reddit sentiments
- AI Price Prediction
- Telegram,WhatsUp,Signal and Alexa notifications
(*) Basic plan will be upgraded to Plus plan for free.
Do I need to download an app?
No. Bioalert is a app-less subscription service.
Why do you ask for my phone number?
We send updates via SMS, that's why we ask your phone number. You will only receive SMS for the biotech updates. We promise!
How can I cancel my subscription?
You can send an email to firstname.lastname@example.org to cancel your subscription.
Can I choose the stocks I want to get updates?
Not in the first version but it is planned for the later versions of the service.
Still have questions? Contact us.
Ready to start?
Register now and have all biotech updates to your mobile
30 days free trial